Combined with the results of pathway enrichment analysis, we were interested in one of the signaling pathways, the JAK–STAT3 signaling pathway, as its dysregulation is closely associated with immune activation and cancer progression (Fig. 3C). The gene discussed is STAT3; the disease is cancer.